BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2009
View Archived Issues
Experiments show TGR5 can be targeted with INT-777 for diabetes and obesity
Read More
LEO-29102 cream evaluated in healthy and psoriatic subjects in phase I and II trials
Read More
Antibacterial agent GSK-1322322 currently evaluated in phase I and II trials by GSK
Read More
Preclinical data on novel lysosomotropic cathepsin K inhibitors presented by Medvir
Read More
DAS-181 shows potent preclinical activity against H1N1, H5N1 and seasonal influenza virus
Read More
New alliance seeks to measure tumor response to protein kinase inhibitors
Read More
Sirona Biochem reports test results for sodium/glucose cotransporter inhibitors
Read More
Alligator Bioscience enters into antibody research agreement with BioInvent
Read More
PTH-CBD fusion protein reduces chemotherapy-induced osteoporosis in mice
Read More
ORM-11984 effective in rat models of osteopenia and osteoporosis
Read More
Mologen reaches milestone in MGN-1703 clinical cancer study
Read More
Chugai files application for approval of Tarceva for pancreatic cancer in Japan
Read More
Novel compounds claimed by The Salk Institute for acute neural injury therapy
Read More
Casein kinase II inhibitors described by Bristol-Myers Squibb as oncolytics
Read More
Sequenom launches SensiGene cystic fibrosis carrier screening test
Read More
Dual PDE4 inhibitors and mAChR agonists in early development at GSK
Read More
Meridian Bioscience cleared to update the Tru Flu package insert
Read More
Phase IIb results reported for GSK-1838262 in neuropathic pain
Read More
Panvax H1N1 vaccine approved for use in Australia
Read More
Johnson & Johnson and Elan closing transaction for Alzheimer's immunotherapy program
Read More
Neogenix obtains IND clearance to commence phase I NPC-1C trials
Read More
Karo Bio expands thyroid hormone receptor platform
Read More
Incyte reports encouraging topline phase IIb results for INCB-18424 in psoriasis
Read More
Rexahn and Teva close a license agreement for RX-3117
Read More
Impax reports results of phase II IPX-066 trial in Parkinson's disease
Read More
BioCryst awarded grant by Department of Health & Human Services for peramivir
Read More